Author:
Merino-Bohórquez Vicente,Berisa-Prado Silvia,Delgado-Valverde Mercedes,Tirado-Pérez María José,García-Palomo Marta,Alonso-Herreros José María,Cañete-Ramírez Carme,Dávila-Pousa María del
Funder
Sociedad Española de Farmacia Hospitalaria
Reference21 articles.
1. Ministerio de Sanidad y Política Social. Real Decreto 1015/2009, de 19 de junio, por el que se regula la disponibilidad de medicamentos en situaciones especiales [Internet]. Sec. 1, Real Decreto 1015/2009 jul 20, 2009 p. 60904-13. [consultado 14 Sep 2023]. Disponible en: https://www.boe.es/eli/es/rd/2009/06/19/1015
2. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome;Marsh;Ophthalmology.,1999
3. Recurrence after topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren’s syndrome;Hong;J Ocul Pharmacol Ther Off J Assoc Ocul Pharmacol Ther,2007
4. Efficacy of combined 0.05% cyclosporine and 1% methylprednisolone treatment for chronic dry eye;Jue;Cornea.,2012